IP & licensing
Structured patent access for teams that need legal certainty.
This page is designed for diligence, procurement, and general-counsel review. It explains the provenance of OMINEX’s patented attestation architecture, the scope of the OCP Pledge, and the commercial licensing paths available when a public promise is not enough.
FOUNDATIONAL TECHNOLOGY
The provenance statement.
OMINEX holds U.S. Patent No. X,XXX,XXX covering the core architecture of permissioned token compliance attestation — the method by which on-chain security tokens verify investor eligibility, enforce transfer restrictions, and produce auditable compliance records.
This technology was developed prior to the publication of ERC-3643 and the commercial deployment of permissioned security token infrastructure. The intent of this page is to make the licensing posture legible for counterparties that need to assess IP certainty as part of procurement, transaction diligence, regulatory disclosure, or M&A review.
At a glance
Public pledge access for qualifying entities.
Commercial licenses for contractual certainty.
Dedicated contact path for counsel-led diligence.
Licensing inquiries
Direct all licensing inquiries to [email protected]. For urgent matters related to pending transactions or regulatory filings, please indicate the nature of the inquiry and expected timeline.
THE OCP PLEDGE
Public access where openness supports responsible market formation.
OMINEX grants a perpetual, royalty-free license to U.S. Patent No. X,XXX,XXX for any entity with annual revenue below $5 million, any entity in active fundraising, and any open-source project implementing the standard in a non-commercial context.
This pledge does not extend to continuation patents, future applications, or commercial tokenization platforms regardless of revenue. The structure is intended to preserve openness for qualifying builders while maintaining a clear commercial pathway for institutions that require contractual certainty.
Read the full OCP PledgeQualifying access
COMMERCIAL LICENSE
Three licensing paths for different diligence thresholds.
The commercial structure is meant to feel operational rather than adversarial. Each path is a productized licensing surface for buyers that need more than a public pledge.
Standard
For entities over $5M revenue
Binding license agreement, Freedom to Operate coverage for standard-compliant implementations.
Contact LicensingEnterprise
For institutions requiring FTO + indemnification
Covers proprietary extensions, provides indemnification against third-party claims, suitable for pre-IPO diligence and regulatory disclosure.
Talk to CounselStrategic
For infrastructure providers and platforms
Sublicensing rights, embedded commercial use, multi-year terms.
Schedule a CallFOR GENERAL COUNSEL
Why legal certainty matters in real diligence workflows.
The OCP Pledge provides a public promise. A commercial license provides a binding contract. For institutions undergoing SEC registration, regulatory examination, or M&A due diligence, a signed license agreement closes the IP gap in a way that a public pledge cannot.
OMINEX licensing counsel is available to discuss the appropriate structure for your organization, including when Freedom to Operate coverage, indemnification, or sublicensing rights are necessary to support internal approval.
Review posture
LICENSING INQUIRIES
Contact licensing counsel directly.
Direct all licensing inquiries to [email protected]. For urgent matters related to pending transactions or regulatory filings, please indicate the nature of the inquiry and expected timeline.
Licensing
Need licensing terms or counsel review?
Route legal, procurement, or strategic diligence into a focused licensing conversation without chasing separate threads.